Pseudomyxoma peritonei: A French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy

European Journal of Surgical Oncology

Volumn 36, Issue 5, 2010, Pages 456-462

  Elias, D ^a   Gilly, F ^b   Quenet, F ^c   Bereder, J M ^d   Sideris L ^e   Mansvelt, B ^f   Lorimier, G ^g   Glehen, O ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c Center Val d'Aurel   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^f Hospital de Jolimont   (Belgium)

^g CENTRE PAUL PAPIN   (France)

Author keywords

Cytoreductive surgery; Hyperthermia; Intraperitoneal chemotherapy; Peritoneal pseudomyxoma; Prognosis

Indexed keywords

FLUOROURACIL; MITOMYCIN C; OXALIPLATIN;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; FRANCE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURGICAL MORTALITY; TUMOR SEEDING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; FRANCE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77952427531     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.01.006     Document Type: Article

References (24)

1. Sugarbaker P.H. New standard of care for appendiceal neoplasms and pseudomyxoma peritonei syndrome. Lancet Oncol 7 (2006) 69-76
2. Brendan M.J., and Cecil T.D. The etiology, clinical presentation and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 12 (2003) 585-603
3. Semino-Mora C., Liu H., McAvoy T., et al. Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 and MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. Ann Surg Oncol 15 (2008) 1414-1423
4. Ronnett B.M., Zahn C.M., Burman R.J., Kass M.E., Sugarbaker P.H., and Shmookler B.M. Disseminated peritoneal adenomucinosis and peritoneal carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 19 (1995) 1390-1409
5. Gough D.B., Donohue J.H., Schutt A.J., et al. Pseudomyxoma peritonei. Long tern patient survival with an aggressive regional approach. Ann Surg 219 (1994) 112-119
6. Miner T.J., Shia J., Jacques D.P., Klimstra D.S., Brennan M.F., and Coit D.G. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 241 (2005) 300-308
7. Yan T.D., Black D., Savady R., and Sugarbaker P.H. A systematic review of the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14 (2007) 484-492
8. Sugarbaker P.H., Cuniffe W., Belliveau J.F., de Bruin E., and Graves T. Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy. Reg Cancer Treat 1 (1988) 66-79
9. Hettinga J.V., Konings A.W., and Kapringa H.H. Reduction of cellular cisplatin resistance by hyperthermia. A review. Int J Hyperthermia 13 (1997) 439-457
10. Murakami A., Koga S., and Maeta M. Thermochemosensitivity: augmentation by hyperthermia of cytotoxicity of anticancer drugs against human colorectal cancer, measured by the human tumor clonogenic assay. Oncology 45 (1988) 236-241
11. Gonzalez-Moreno S., and Sugarbaker P. Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding. Br J Surg 91 (2004) 304-311
12. Sugarbaker P., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6 (1999) 727-731
13. Smeenk R.M., Verwaal V., Antonini N., and Zoetmulder F. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245 (2007) 104-109
14. Stewart J.H., Shen P., Russell G.B., et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 13 (2006) 624-634
15. Elias D., Honoré C., Ciuchundea R., et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 95 (2008) 1164-1171
16. Chua T.C., Yan T.D., Smigielski M.E., et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol 16 (2009) 1903-1911
17. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 221 (1995) 29-42
18. Recommandations de la Société Française de Chirurgie Digestive (SFCD), and de l'Association de Chirurgie Hépato-biliaire (ACHBT). Cancérologie digestive: pratiques chirurgicales. J Chir (Paris) 146 Suppl. 2 (2009) 560-562
19. Elias D., Gilly F., Boutitie F., et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy. Analysis of 523 patients from a multicentric French study. J Clin Oncol 27 (2009) 681-685
20. Gomez da Silva R., and Sugarbaker P.H. Analysis of prognostic factors in seventy patients having a complete cytoreduction pus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer. J Am Coll Surg 203 (2006) 878-886
21. Verwaal V.J., van Ruth S., Witkamp A., et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 12 (2005) 65-71
22. Elias D., Blot F., El Otmany A., et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92 (2001) 71-76
23. Glehen O., Mohamed F., and Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 240 (2004) 278-285
24. Koga S., Hamazoe R., Maeta M., et al. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 44 (1984) 1840-1842